Schroder Investment Management Group’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-19,803
Closed -$961K 1320
2022
Q4
$961K Buy
19,803
+6,411
+48% +$402K ﹤0.01% 1058
2022
Q3
$945K Buy
+13,392
New +$1.15M ﹤0.01% 1052
2021
Q4
Sell
-4,744
Closed -$610K 1501
2021
Q3
$610K Sell
4,744
-2,413
-34% -$338K ﹤0.01% 1182
2021
Q2
$1.09M Sell
7,157
-1,317
-16% -$173K ﹤0.01% 1115
2021
Q1
$893K Buy
+8,474
New +$848K ﹤0.01% 1184

Other funds holding STAA

Schroder Investment Management Group's STAA Position: Q1 2023 in Review

Schroder Investment Management Group sold out of STAAR Surgical (STAA) in Q1 2023, closing a stake of 19,803 shares — an estimated $961K sold.

Schroder Investment Management Group first reported a position in STAA in Q1 2021 and held it in 5 quarters. The position peaked at $1.09M in Q2 2021. 251 funds tracked by Wall St. Rank hold STAA as of Q1 2023.

  • Schroder Investment Management Group reported no remaining STAAR Surgical position as of Q1 2023 after selling out during the quarter.
  • Schroder Investment Management Group sold 19,803 STAAR Surgical shares in Q1 2023, an estimated $961K.
  • Schroder Investment Management Group first reported a position in STAAR Surgical in Q1 2021 and held it in 5 quarters.
  • Schroder Investment Management Group's STAAR Surgical position peaked at $1.09M in Q2 2021.
  • 251 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2023.

Based on Schroder Investment Management Group's 13F filing for Q1 2023, filed 11 May 2023.